Pulse Biosciences has appointed Jon Skinner as Chief Financial Officer starting February 3, 2025, with an annual salary of $400,000, a potential bonus of 50%, and stock options for 300,000 shares at an exercise price of $20.93, vesting based on performance and market capitalization milestones.